Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated ...
Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
Company welcomes additional late-stage expertise as it prepares for amezalpat pivotal studyBRISBANE, Calif., Sept. 18, 2024 ...
bovnews4d
Why Did Tempest Therapeutics Inc (TPST) Stock Rise 11.03% to $1.51?
Scotiabank has recently initiated Tempest Therapeutics Inc (TPST) stock to Sector Outperform rating, as announced on March 14, 2024, according to Finviz. Analyst ratings are significant because they ...
Business Insider4d
Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
BRISBANE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated ...
Mena FN4d
Tempest Further Strengthens Leadership Team With Appointment Of Sheldon Mullins As Vice President, Regulatory Affairs
Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight ...
Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated ...
Mena FN17d
Tempest To Present At The H.C. Wainwright 26Th Annual Global Investment Conference
(MENAFN- GlobeNewsWire - Nasdaq) BRISBANE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology ...
Morningstar5d
Tempest Therapeutics Inc 3OS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
BioMarin Pharmaceutical (BMRN) Gets a Hold from Scotiabank
In a report released today, George Farmer from Scotiabank maintained a Hold rating on BioMarin Pharmaceutical (BMRN – Research Report), ...